Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 11
Results: 13
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1339, doi. 10.1007/s00262-016-1890-x
- By:
- Publication type:
- Article
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1303, doi. 10.1007/s00262-016-1884-8
- By:
- Publication type:
- Article
NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1325, doi. 10.1007/s00262-016-1885-7
- By:
- Publication type:
- Article
Quantification of PD-L1 and PD-1 expression on tumor and immune cells in non-small cell lung cancer (NSCLC) using non-enzymatic tissue dissociation and flow cytometry.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1317, doi. 10.1007/s00262-016-1889-3
- By:
- Publication type:
- Article
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1353, doi. 10.1007/s00262-016-1893-7
- By:
- Publication type:
- Article
The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1365, doi. 10.1007/s00262-016-1894-6
- By:
- Publication type:
- Article
Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1377, doi. 10.1007/s00262-016-1897-3
- By:
- Publication type:
- Article
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1395, doi. 10.1007/s00262-016-1898-2
- By:
- Publication type:
- Article
'Cancer Bio-Immunotherapy in Siena': Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015.
- Published in:
- 2016
- By:
- Publication type:
- Report
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1411, doi. 10.1007/s00262-016-1900-z
- By:
- Publication type:
- Article
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1401, doi. 10.1007/s00262-016-1902-x
- By:
- Publication type:
- Article
Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Beta-glucan contamination of pharmaceutical products: How much should we accept?
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 11, p. 1289, doi. 10.1007/s00262-016-1875-9
- By:
- Publication type:
- Article